Urol. praxi, 2012; 13(5): 209-211

Comprehensive candidiasis treatment

doc.MUDr.Růžena Pánková, CSc.
Dermatovenerologická klinika 1. LF UK a VFN, Praha

An infection caused by the Candida albicans yeast, occasionally by other species of the genus Candida, is referred to as candidiasis (syn.

candidosis, moniliasis). It is a fungus that is an indispensable part of the human organism. In a healthy person, it is in balance and symbiosis

with the other microorganisms in the oral and intestinal microflora. When an infection develops, both factors increasing the colonization

rate of the mucosa with yeast and those increasing the host’s susceptibility to colonization of the skin and mucosa with yeast are involved.

Superficial mucosal and skin infections are quantitatively clinically most significant, but systemic Candida infections of internal organs in

septicaemia, endocarditis, meningitis, pneumonia, and hepatosplenic and renal involvement are more severe and life threatening. Candidiasis

is the most frequent mycosis with a number of different clinical presentations of varying severity. Comprehensive candidiasis treatment

involves effective local and systemic azole, triazole and polyene antifungal agents and echinocandins as well as general principles of comprehensive

treatment, including interdisciplinary collaboration, targeted therapy of possible concomitant conditions, and reducing longterm

use of broad-spectrum antibiotics, corticosteroids and/or immunosuppressants according to the patient’s health condition. Effective

comprehensive treatment and prevention of the spread of yeast infection also include patient education on side effects of some drugs and

on the effects of lifestyle, nutrition, improper clothing, hygiene and sexual risk behaviour on the development of recurrent candidiases.

Keywords: aetiology and pathogenesis of Candida infections, comprehensive treatment, antifungal drugs, prevention

Published: October 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pánková R. Comprehensive candidiasis treatment. Urol. praxi. 2012;13(5):209-211.
Download citation

References

  1. Hay RJ, Moore MK. Mycology (p 1405-1506), chapter 31 in Rook's Textbook of Dermatology, Seventh Edition Edited by Tony Burns, Neil Cox Christopher Griffiths Copyright (C) 2004 by Blackwell Science Ltd. Go to original source...
  2. Mašata J, Jedličková A, a kol. Infekce v gynekologii a porodnictví. Maxdorf, Praha 2004.
  3. Staňková M, Marešová M, Vaništa J. Repetitorium infekčních nemocí. Praha: Triton 2008, http://www.tridistri.cz.
  4. Kuklová I, Kaštánková V, Pánková R, Binder T, Hrušková H. Souvislosti mykotických vulvovaginitid u žen vyšetřených na venerologické ambulanci I. kožní kliniky. Čs. Derm, 72, 1997: 134-136.
  5. Kuklová I. Vulvovaginální kandidóza. Referátový výběr z dermatovenerologie, roč. 52, Speciál II, 2010: 17-22.
  6. Kuklová I. Kožní mykózy. in Dermatovenerologie, dětská dermatologie a korektivní dermatologie. Kolektiv autorů. Trendy v medicíně. Triton: Praha 2006, www.tridistri.cz.
  7. Vosmík F, Skořepová M. Dermatomykózy. 1. vyd. Praha, Galén 1995. 140 s.
  8. Arenberger P, Jírová M. Onychomykózy. Trendy v medicíně, 3, 2001: 56-60.
  9. Velčevský P, Kuklová I. Léčba sexuálně přenosných onemocnění. Čes-slov Derm 2008; 83: 123-136.
  10. Kuklová I. Sexuálně přenosná onemocnění. In: Weiss a kolektiv. Sexuologie. Praha, Grada, 2010: 579-612.
  11. Štork J, et al. Candidosis in Dermatovenerologie, Galén, Karolinum, 2008: 76-78.
  12. Kršek M. Endokrinologie in Interna, Čéška R, a kol., 2010, Triton, Isbn.
  13. Ahonen P, Myllarniemi S, Sipila I, et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322: 1829-1836. Go to original source... Go to PubMed...
  14. Meriluoto T, Halonen M, Pelto-Huikko M, et al. The autoimmune regulator: a key toward understanding the molecular pathogenesis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Keio J Med 2001; 50: 225-239. Go to original source... Go to PubMed...
  15. Slíva J, Votava M. Farmakologie. Praha: Triton 2010, http://www.tridistri.cz.
  16. ##
  17. Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012; 36(2): 288-305. Go to original source... Go to PubMed...
  18. Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis 2006; 43(Suppl 1): S15-S27. Go to original source...
  19. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20(1): 133-163. Go to original source... Go to PubMed...
  20. Playford EG, Lipman J, Sorrell TC. Management of invasive candidiasis in the intensive care unit. Drugs 2010; 70(7): 823-839. Go to original source... Go to PubMed...
  21. Hamal P, Raclavský V, Svobodová L, et al. Současné možnosti antimykotické léčby invazivní kandidózy na jednotkách intenzivní péče. Klin Mikrobiol Infekc Lek 2010; 16(5): 164-170. Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.